| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 7, 2007
Revised on December 13, 2007
Accepted on December 17, 2007
From the Departments of Physiology & Biophysics (M.F.N., M.N.-C., G.C.A., C.Y., V.S.V., L.F.S.) and Pharmacology (G.S.M.), University of Washington, Seattle; and Medical Biotechnology Center (W.J.L.), University of Maryland Biotechnology Institute, Baltimore.
* To whom correspondence should be addressed. E-mail: santana{at}u.washington.edu.
Hypertension is a perplexing multiorgan disease involving renal primary pathology and enhanced angiotensin II vascular reactivity. Here, we report that a novel form of a local Ca2+ signaling in arterial smooth muscle is linked to the development of angiotensin II–induced hypertension. Long openings and reopenings of L-type Ca2+ channels in arterial myocytes produce stuttering persistent Ca2+ sparklets that increase Ca2+ influx and vascular tone. These stuttering persistent Ca2+ sparklets arise from the molecular interactions between the L-type Ca2+ channel and protein kinase C
at only a few subsarcolemmal regions in resistance arteries. We have identified AKAP150 as the key protein, which targets protein kinase C
to the L-type Ca2+ channels and thereby enables its regulatory function. Accordingly, AKAP150 knockout mice (AKAP150-/-) were found to lack persistent Ca2+ sparklets and have lower arterial wall intracellular calcium ([Ca2+]i) and decreased myogenic tone. Furthermore, AKAP150-/- mice were hypotensive and did not develop angiotensin II–induced hypertension. We conclude that local control of L-type Ca2+ channel function is regulated by AKAP150-targeted protein kinase C
signaling, which controls stuttering persistent Ca2+ influx, vascular tone, and blood pressure under physiological conditions and underlies angiotensin II–dependent hypertension.
This article has been cited by other articles:
![]() |
C. W. Dessauer Adenylyl Cyclase-A-kinase Anchoring Protein Complexes: The Next Dimension in cAMP Signaling Mol. Pharmacol., November 1, 2009; 76(5): 935 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S Kirschner, Z. Yin, G. N Jones, and E. Mahoney Mouse models of altered protein kinase A signaling Endocr. Relat. Cancer, September 1, 2009; 16(3): 773 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. McCarron, M. L. Olson, S. Currie, A. J. Wright, K. I. Anderson, and J. M. Girkin Elevations of intracellular calcium reflect normal voltage-dependent behavior, and not constitutive activity, of voltage-dependent calcium channels in gastrointestinal and vascular smooth muscle J. Gen. Physiol., April 1, 2009; 133(4): 439 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wong, A. S. Goehring, M. S. Kapiloff, L. K. Langeberg, and J. D. Scott mAKAP Compartmentalizes Oxygen-Dependent Control of HIF-1{alpha} Sci. Signal., December 23, 2008; 1(51): ra18 - ra18. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nieves-Cintron, G. C. Amberg, M. F. Navedo, J. D. Molkentin, and L. F. Santana The control of Ca2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension PNAS, October 7, 2008; 105(40): 15623 - 15628. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Tunquist, N. Hoshi, E. S. Guire, F. Zhang, K. Mullendorff, L. K. Langeberg, J. Raber, and J. D. Scott Loss of AKAP150 perturbs distinct neuronal processes in mice PNAS, August 26, 2008; 105(34): 12557 - 12562. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |